Investor News

As communicated in 2013/2014 Year-End Report, Phase Holographic Imaging (PHI) has successfully reached the milestones of the initial funding period. PHI has therefore initiated the planned second funding round by securing 3 MSEK from investors and ALMI. These funds allow PHI to immediately progress towards the milestones of the second funding period, including the establishment …

PHI has signed a collaboration agreement with the University of Pittsburgh. This agreement makes the fourth with key opinion leaders at leading research institutions and completes the first milestone described in PHI’s offering memorandum. The collaboration agreement was signed after the research group lead by Professor Jay Kolls evaluated the HoloMonitor® M4 and made important, previously …

Phase Holographic Imaging (PHI) and Israeli Biological Industries (BI) have initiated a strategic collaboration. BI is a well-established and recognized supplier of stem cell technology. In a first step BI will represent PHI on the Israeli market. “We develop, manufacture and supply life science products to universities, government research and healthcare institutions and to the …

The Research Institute of Technical Physics and Materials Science in Budapest has recently published a scientific article describing a study of the health effects of the well-known, widely used herbicide Roundup. In the study, the HoloMonitor M4 was used to assess toxic effects to animal cells after exposure to Roundup. “New European Union legislation requires …

Phase Holographic Imaging’s (PHI) Eastern Europe distributor, BioTech-Europe, has placed a follow-up order of two HoloMonitor M4 instruments. The ordered instruments replace the evaluation units that were previously sold to the cell therapy company Aztar and to the Tissue Engineering Laboratory at the Medical University of Warsaw, subsequent to careful evaluations. “We are very pleased …

The Department of Cell Biology and Human Anatomy at University of California, Davis, has purchased a HoloMonitor M4 after a successful evaluation period. PHI’s US distributor, Bulldog Bio, has placed a number of HoloMonitor M4 instruments which currently are being evaluated by US customers. “We are very pleased that our groundwork with key opinion leaders …

PHI announces the signing of a collaboration agreement with the Cell Systems Dynamics Group at ETH Zurich. The group, headed by Professor Timm Schroeder, is a leading authority in stem cell time-lapse imaging and will advise PHI in the development of the next generation of time-lapse cytometers. Professor Timm Schroeder at one of his microscopes. …

PHI announces the signing of a collaboration agree­ment with Korea Research Institute of Bioscience and Biotechnology (KRIBB). KRIBB is Korea’s only governmental research institute dedicated to research across a broad span of biotechnology research areas. “We are of course pleased to have estab­lished a col­labora­tion with an opinion leader like KRIBB. This is very helpful …